ACAnderson Valério Chaves

Anderson Valério Chaves

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anderson Valério Chaves has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Unsaturation-Driven Modulation of Antioxidant and Acetylcholinesterase Inhibitory Activities of Cardanol Derivatives

    by Roberta Bussons Rodrigues Valério, Halisson de Souza, Vitor Martins, Katherine Silva, Jane Eire de Manezes, Anderson Chaves, Leonardo F. Serafim, Antônio Vieira-Neto, José Cleiton S. dos Santos, Selene de Morais

    Background: Cardanol, a bioactive alkylphenol obtained from technical cashew nutshell liquid (CNSL), consists of mono-, di-, and tri unsaturated side chain derivatives. These compounds are of increasing interest for their diverse industrial applications. Methods: In this study, three major cardanol components—3-[(8E)-8-pentadecen-1-yl] phenol (C1), 3-[(8E,11E)-8,11-pentadecadien-1-yl] phenol (C2), and 3-[(8E,11E,14E)-8,11,14-pentadecatrien-1-yl] phenol (C3)—were isolated from CNSL via chromatographic separation. Their structures were confirmed by FTIR and detailed 1H and 13C NMR spectroscopy, with complete carbon and proton assignments reported. Results: Among the three, C3 exhibited the highest antioxidant potential, with a DPPH IC50 value of 0.179 ± 0.005 mg/mL, approximately five times more potent than C1 (IC50 = 1.000 ± 0.200 mg/mL). C3 also showed the highest lethality against Artemia salina (LC50 = 4.118 ± 0.328 mg/mL) and the most pronounced inhibition of acetylcholinesterase (AChE), with a 0.8 cm inhibition zone. Computational studies using molecular docking and molecular dynamics simulations further supported the interaction of these compounds with both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE. Conclusions: These results expand our understanding of the chemical composition and potential applications of CNSL. The identified unsaturated alkylphenols, particularly the triene compound, demonstrate promise as sustainable candidates for the development of new materials and pharmaceuticals that combat oxidative stress and neurodegenerative diseases.


  • Open Access

    Chitosan-Based Nanoparticles for Cardanol-Sustained Delivery System

    by Roberta Bussons Rodrigues Valério, Nilvan Alves da Silva, José Ribamar Paiva Junior, Anderson Valério Chaves, Bruno Peixoto de Oliveira, Nágila Freitas Souza, Selene Maia de Morais, José Cleiton Sousa dos Santos, Flávia Oliveira Monteiro da Silva Abreu

    Cardanol, principal constituent of the technical cashew nut shell liquid, has applications as antioxidant and antibacterial, and these properties may be enhanced through encapsulation. In the present study, we isolated and purified cardanol, and nanoparticles (NPs) were produced by polyelectrolyte complexation using polysaccharide systems with chitosan, sodium alginate, and non-toxic Arabic gum, because they are biocompatible, biodegradable, and stable. We characterized the NPs for morphological, physicochemical, and antioxidant activity. The micrographs obtained revealed spherical and nanometric morphology, with 70% of the distribution ranging from 34 to 300 nm, presenting a bimodal distribution. The study of the spectra in the infrared region suggested the existence of physicochemical interactions and cross-links between the biopolymers involved in the encapsulated NPs. Furthermore, the NPs showed better antioxidant potential when compared to pure cardanol. Thus, the encapsulation of cardanol may be an effective method to maintain its properties, promote better protection of the active ingredient, minimize side effects, and can target its activities in specific locations, by inhibiting free radicals in various sectors such as pharmaceutical, nutraceutical, and biomedical.


  • Taguchi design-assisted co-immobilization of lipase A and B from Candida antarctica onto chitosan: Characterization, kinetic resolution application, and docking studies

    by Katerine da S. Moreira, André Luiz Barros de Oliveira, Lourembergue Saraiva de Moura Júnior, Isamayra Germano de Sousa, Antonio Luthierre Gama Cavalcante, Francisco Simão Neto, Roberta Bussons Rodrigues Valério, Anderson Valério Chaves, Thiago de Sousa Fonseca, Daniel Morais Vieira Cruz, et al.


  • Open Access

    Hydroxyapatite-Based Magnetic Bionanocomposite as Pharmaceuticals Carriers in Chitosan Scaffolds

    by Anderson Valério Chaves, Rafael Melo Freire, Victor Pinheiro Feitosa, Nágila Maria Pontes Silva Ricardo, Juliano Casagrande Denardin, Davino Machado Andrade Neto, Pierre Basílio Almeida Fechine

    Hydroxyapatite (HA) is a bioceramic very similar to the mineral component of bones and teeth. It is well established that osteoblasts grow better onto HA-coated metals than on metals alone. Herein, the preparation of a new system consisting of magnetite (Fe3O4) and HA functionalized with oleic acid and simvastatin (SIMV), and incorporated in chitosan (CHI) scaffolds, was undertaken. HA was synthesized by the hydrothermal method, while Fe3O4 was synthesized by co-precipitation. The polymer matrix was obtained using a 2% CHI solution, and allowed to stir for 2 h. The final material was freeze-dried to produce scaffolds. The magnetic properties remained unchanged after the formation of the composite, as well as after the preparation of the scaffolds, maintaining the superparamagnetism. CHI scaffolds were analyzed by scanning electronic spectroscopy (SEM) and showed a high porosity, with very evident cavities, which provides the functionality of bone growth support during the remineralization process in possible regions affected by bone tissue losses. The synthesized composite showed an average particle size between 15 and 23 nm for particles (HA and Fe3O4). The scaffolds showed considerable porosity, which is important for the performance of various functions of the tissue structure. Moreover, the addition of simvastatin in the system can promote bone formation.